Insider Transactions in Q4 2020 at Laboratory Corp Of America Holdings (LH)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2020
|
Kerrii B Anderson Director |
SELL
Bona fide gift
|
Direct |
746
-3.8%
|
-
|
|
Dec 01
2020
|
Jeffrey A. Davis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
173
+50.0%
|
-
|
|
Nov 06
2020
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Open market or private sale
|
Direct |
588
-12.96%
|
$125,832
$214.59 P/Share
|
|
Nov 05
2020
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
835
-15.54%
|
$178,690
$214.42 P/Share
|
|
Nov 05
2020
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,010
+27.23%
|
-
|
|
Nov 05
2020
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
886
-17.35%
|
$189,604
$214.42 P/Share
|
|
Nov 05
2020
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,010
+28.24%
|
-
|
|
Nov 04
2020
|
Paul R Kirchgraber CEO, Covance Drug Development |
SELL
Open market or private sale
|
Direct |
1,500
-16.31%
|
$321,000
$214.14 P/Share
|
|
Nov 02
2020
|
Paul R Kirchgraber CEO, Covance Drug Development |
SELL
Payment of exercise price or tax liability
|
Direct |
895
-8.87%
|
$185,265
$207.23 P/Share
|
|
Nov 02
2020
|
Paul R Kirchgraber CEO, Covance Drug Development |
BUY
Exercise of conversion of derivative security
|
Direct |
2,006
+17.9%
|
-
|
|
Nov 02
2020
|
Adam H Schechter President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
885
-9.13%
|
$183,195
$207.23 P/Share
|
|
Nov 02
2020
|
Adam H Schechter President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,006
+17.14%
|
-
|
|
Nov 02
2020
|
Glenn A Eisenberg Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,034
-11.48%
|
$835,038
$207.23 P/Share
|
|
Nov 02
2020
|
Glenn A Eisenberg Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
9,024
+20.43%
|
-
|